Search results

https://pace-cme.org/2023/10/16/discontinuation-of-dual-gip-and-glp-1-receptor-agonist-leads-to-weight-regain-in-people-with-obesity-or-overweight/ “Participants who discontinued treatment with tirzepatide for one year regained body weight, but not to baseline weight (9.5% below baseline).” I...

Is this where the researchers who actually know how to do math hang out? 😆